OTC drug private label giant Perrigo Co. PLC will change its focus from health care to "self care" and compete outside its core sector to solve its revenue problems, says recently appointed CEO Murray Kessler.
During Perrigo's 2018 third-quarter earnings briefing Nov. 8, Kessler also said the firm's Rx generics business will see some changes...


